Fundraising Fox

Kempharm

NASDAQ: ZVRA

Coralville, US · Founded 2014 · Delaware corporation

Biotech

Founders & leadership

Kempharm was founded in 2014 by Travis C. Mickle and Christal M.M. Mickle.

TC
Travis C. MickleCo-founder
CM
Christal M.M. MickleCo-founder
GK
Gordon K. JohnsonExecutive
TM
Tracy M. WoodyExecutive
SG
Sven GuentherExecutive

Board

MR
Matthew R. PloosterBoard director
JS
Jonathan S. LeffBoard director
DS
David S. TierneyBoard director
RW
Richard W. PascoeBoard director
DL
Danny L. ThompsonBoard director
JB
Joseph B. SaluriBoard director

Reported raises · per SEC filings

Form D private placements

$194.2M disclosed across 7 rounds · 2015–2021

▶$39.1MraisedJun 2021 · 12 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • R. LaDuane CliftonExecutive Officer
  • Timothy J. SangiovanniExecutive Officer
  • Travis C. MickleExecutive Officer, Director, Promoter
  • Joseph B. SaluriDirector
  • Sven GuentherExecutive Officer
  • David S. TierneyDirector
  • Matthew R. PloosterDirector
  • Richard W. PascoeDirector
Offering amount
$39.1M
Amount sold
$39.1M
Sales commissions
$2.3M
Placement agents
Roth Capital Partners, LLC
First sale
Jun 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$44MraisedFeb 2021 · 15 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Sven GuentherExecutive Officer
  • Timothy J. SangiovanniExecutive Officer
  • Richard W. PascoeDirector
  • Matthew R. PloosterDirector
  • Joseph B. SaluriDirector
  • David S. TierneyDirector
  • Travis C. MickleExecutive Officer, Director, Promoter
  • R. LaDuane CliftonExecutive Officer
Offering amount
$44M
Amount sold
$44M
Sales commissions
$2.6M
Placement agents
Roth Capital Partners, LLC
First sale
Jan 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$31.5MraisedJan 2021 · 4 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Joseph B. SaluriDirector
  • David S. TierneyDirector
  • Travis C. MickleExecutive Officer, Director, Promoter
  • Matthew R. PloosterDirector
  • Sven GuentherExecutive Officer
  • Timothy J. SangiovanniExecutive Officer
  • Richard W. PascoeDirector
  • R. LaDuane CliftonExecutive Officer
Offering amount
$31.5M
Amount sold
$31.5M
Finders' fees
$2M
Placement agents
Cowen & Company, LLC
First sale
Jan 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedJan 2020 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • R. LaDuane CliftonExecutive Officer
  • Gordon K. JohnsonExecutive Officer
  • Sven GuentherExecutive Officer
  • David S. TierneyDirector
  • Richard W. PascoeDirector
  • Matthew R. PloosterDirector
  • Joseph B. SaluriDirector
  • Travis C. MickleExecutive Officer, Director, Promoter
  • Timothy J. SangiovanniExecutive Officer
Offering amount
$3M
Amount sold
$3M
First sale
Jan 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$71.4MraisedDec 2019 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Travis C. MickleExecutive Officer, Director, Promoter
  • R. LaDuane CliftonExecutive Officer
  • Gordon K. JohnsonExecutive Officer
  • Sven GuentherExecutive Officer
  • David S. TierneyDirector
  • Richard W. PascoeDirector
  • Matthew R. PloosterDirector
  • Joseph B. SaluriDirector
  • Timothy J. SangiovanniExecutive Officer
Offering amount
$71.4M
Amount sold
$71.4M
Sales commissions
$530K
Placement agents
Cowen & Company, LLC
First sale
Dec 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.1MraisedNov 2018 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard W. PascoeDirector
  • Joseph B. SaluriDirector
  • R. LaDuane CliftonExecutive Officer
  • Sven GuentherExecutive Officer
  • Travis C. MickleExecutive Officer, Director, Promoter
  • David S. TierneyDirector
  • Matthew R. PloosterDirector
  • Danny L. ThompsonDirector
  • Gordon K. JohnsonExecutive Officer
  • Timothy J. SangiovanniExecutive Officer
Offering amount
$1.1M
Amount sold
$1.1M
First sale
Oct 2018
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4MraisedMar 2015 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Gordon K. JohnsonExecutive Officer
  • David S. TierneyDirector
  • Matthew R. PloosterDirector
  • Travis C. MickleExecutive Officer, Director, Promoter
  • Tracy M. WoodyExecutive Officer
  • Richard W. PascoeDirector
  • Christal M.M. MickleExecutive Officer, Director
  • Danny L. ThompsonDirector
  • Joseph B. SaluriDirector
  • Sven GuentherExecutive Officer, Director
  • Jonathan S. LeffDirector
Offering amount
$4M
Amount sold
$4M
First sale
Feb 2015
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded Kempharm?
Kempharm was founded by Travis C. Mickle, Christal M.M. Mickle in 2014.
How much funding has Kempharm raised?
Kempharm has disclosed $194.2M raised across 7 rounds.
Where is Kempharm headquartered?
Kempharm is headquartered in Coralville, US.